A Phase 1b/2a Dose Escalation and Confirmation Study of PT-112 in Advanced Solid Tumors in Combination with Avelumab

This Study is
No Longer Enrolling

Details
Age

Adult

Type of Study

Treatment

Locations

University of Colorado Hospital

Study ID

Protocol Number: 18-0187

More information available at ClinicalTrials.gov: NCT03409458

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers